Who would be the winner? A prognostic nomogram for predicting the benefit of postoperative radiotherapy ± chemotherapy in patients with locally advanced gastric cancer: TROD-02-01 study

被引:1
作者
Sert, Fatma [1 ]
Gorken, Ilknur Bilkay [2 ]
Ozkok, Serdar [1 ]
Oksuz, Didem Colpan [3 ]
Yucel, Birsen [4 ]
Saglam, Esra Kaytan [5 ]
Aksu, Gamze [6 ]
Cetin, Eren [7 ]
Aktan, Meryem [8 ]
Canyilmaz, Emine [9 ]
Okumus, Nilgun Ozbek [9 ]
Yildirim, Berna [10 ,11 ]
Akyurek, Serap [12 ]
Serin, Meltem [13 ]
Kurt, Meral [14 ]
Alicikus, Zumre Arican [2 ]
Erdis, Eda [4 ]
Yalman, Deniz [1 ]
机构
[1] Ege Univ, Fac Med, Dept Radiat Oncol, Univ Cad 1, Izmir, Turkiye
[2] Dokuz Eylul Univ, Fac Med, Dept Radiat Oncol, Izmir, Turkiye
[3] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Radiat Oncol, Istanbul, Turkiye
[4] Sivas Cumhuriyet Univ, Fac Med, Dept Radiat Oncol, Sivas, Turkiye
[5] Biruni Univ, Dept Radiat Oncol, Istanbul, Turkiye
[6] Akdeniz Univ, Fac Med, Dept Radiat Oncol, Antalya, Turkiye
[7] Gazi Univ, Fac Med, Dept Radiat Oncol, Ankara, Turkiye
[8] Necmettin Erbakan Univ, Fac Med, Dept Radiat Oncol, Konya, Turkiye
[9] Karadeniz Tech Univ, Fac Med, Dept Radiat Oncol, Trabzon, Turkiye
[10] Ondokuz Mayis Univ, Fac Med, Dept Radiat Oncol, Samsun, Turkiye
[11] Univ Hlth Sci, Prof Dr Cemil Tascioglu City Hosp, Dept Radiat Oncol, Istanbul, Turkiye
[12] Ankara Univ, Fac Med, Dept Radiat Oncol, Ankara, Turkiye
[13] Acibadem Mehmet Ali Aydinlar Univ, Adana Hosp, Dept Radiat Oncol, Adana, Turkiye
[14] Bursa Uludag Univ, Fac Med, Dept Radiat Oncol, Bursa, Turkiye
关键词
Gastric cancer; Nomogram; Radiotherapy; PHASE-III TRIAL; ADJUVANT CHEMOTHERAPY; D2; GASTRECTOMY; SURVIVAL; CHEMORADIOTHERAPY; ADENOCARCINOMA; CAPECITABINE; RESECTION; SURGERY; IMPACT;
D O I
10.1016/j.asjsur.2024.02.100
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives: We aimed to develop a basic, easily applicable nomogram to improve the survival prediction of the patients with stage II/III gastric cancer (GC) and to select the best candidate for postoperative radiotherapy (RT). Methods: In this multicentric trial, we retrospectively evaluated the data of 1597 patients with stage II/III GC after curative gastrectomy followed by postoperative RT +/- chemotherapy (CT). Patients were divided into a training set (n = 1307) and an external validation set (n = 290). Nomograms were created based on independent predictors identified by Cox regression analysis in the training set. The consistency index (C-index) and the calibration curve were used to evaluate the discriminative ability and accuracy of the nomogram. A nomogram was created based on the predictive model and the identified prognostic factors to predict 5-year cancer-specific survival (CSS) and progression-free survival (PFS). Results: The multivariate Cox model recognized lymph node (LN) involvement status, lymphatic dissection (LD) width, and metastatic LN ratio as covariates associated with CSS. Depth of invasion, LN involvement status, LD width, metastatic LN ratio, and lymphovascular invasion were the factors associated with PFS. Calibration of the nomogram predicted both CSS and PFS corresponding closely with the actual results. In our validation set, discrimination was good (C-index, 0.76), and the predicted survival was within a 10% margin of ideal nomogram. Conclusions: In our relatively large cohort, we created and validated both CSS and PFS nomograms that could be useful for underdeveloped or developing countries rather than Korea and Japan, where the D2 gastrectomy is routinely performed. This could serve as a true map for oncologists who must make decisions without an experienced surgeon and a multidisciplinary tumor board. (c) 2024 Asian Surgical Association and Taiwan Society of Coloproctology. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/ by-nc-nd/4.0/).
引用
收藏
页码:3056 / 3062
页数:7
相关论文
共 26 条
[1]  
[Anonymous], 2002, AJCC Cancer Staging Manual, V6th
[2]  
Balakrishnan Maya, 2017, Curr Gastroenterol Rep, V19, P36, DOI [10.1007/s11894-017-0575-8, 10.1007/s11894-017-0575-8]
[3]   Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial [J].
Bang, Yung-Jue ;
Kim, Young-Woo ;
Yang, Han-Kwang ;
Chung, Hyun Cheol ;
Park, Young-Kyu ;
Lee, Kyung Hee ;
Lee, Keun-Wook ;
Kim, Yong Ho ;
Noh, Sang-Ik ;
Cho, Jae Yong ;
Mok, Young Jae ;
Kim, Yeul Hong ;
Ji, Jiafu ;
Yeh, Ta-Sen ;
Button, Peter ;
Sirzen, Florin ;
Noh, Sung Hoon .
LANCET, 2012, 379 (9813) :315-321
[4]   Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial [J].
Cats, Annemieke ;
Jansen, Edwin P. M. ;
van Grieken, Nicole C. T. ;
Sikorska, Karolina ;
Lind, Pehr ;
Nordsmark, Marianne ;
Kranenbarg, Elma Meershoek-Klein ;
Boot, Henk ;
Trip, Anouk K. ;
Swellengrebel, H. A. Maurits ;
van Laarhoven, Hanneke W. M. ;
Putter, Hein ;
van Sandick, Johanna W. ;
Henegouwen, Mark I. van Berge ;
Hartgrink, Henk H. ;
van Tinteren, Harm ;
van de Velde, Cornelis J. H. ;
Verheij, Marcel .
LANCET ONCOLOGY, 2018, 19 (05) :616-628
[5]   Precision medicine in the adjuvant treatment of gastric cancer [J].
Gambardella, Valentina ;
Cervantes, Andres .
LANCET ONCOLOGY, 2018, 19 (05) :583-584
[6]   Nomogram Predicting Long-Term Survival After D2 Gastrectomy for Gastric Cancer [J].
Han, Dong-Seok ;
Suh, Yun-Suhk ;
Kong, Seong-Ho ;
Lee, Hyuk-Joon ;
Choi, Yunhee ;
Aikou, Susumu ;
Sano, Takeshi ;
Park, Byung-Joo ;
Kim, Woo-Ho ;
Yang, Han-Kwang .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (31) :3834-3840
[7]  
Harrell F., 2001, REGRESSION MODELING, V2nd
[8]   ASSESSING TIME-BY-COVARIATE INTERACTIONS IN PROPORTIONAL HAZARDS REGRESSION-MODELS USING CUBIC SPLINE FUNCTIONS [J].
HESS, KR .
STATISTICS IN MEDICINE, 1994, 13 (10) :1045-1062
[9]   Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer [J].
Jiang, Yuming ;
Li, Tuanjie ;
Liang, Xiaoling ;
Hu, Yanfeng ;
Huang, Lei ;
Liao, Zhenchen ;
Zhao, Liying ;
Han, Zhen ;
Zhu, Shuguang ;
Wang, Menglan ;
Xu, Yangwei ;
Qi, Xiaolong ;
Liu, Hao ;
Yang, Yang ;
Yu, Jiang ;
Liu, Wei ;
Cai, Shirong ;
Li, Guoxin .
JAMA SURGERY, 2017, 152 (07) :e171087
[10]   Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma [J].
Kattan, MW ;
Karpeh, MS ;
Mazumdar, M ;
Brennan, MF .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) :3647-3650